Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (104)

« Back to Publications

Towards the Rational Design of a Next-Generation Dendritic Cell Vaccine for Cancer Immunotherapy

FAIRCHILD P. et al, (2021), Cell and Gene Therapy Insights

Modelling late-onset diseases with induced pluripotent stem cells: a matter of time management

FAIRCHILD P. and Cossins C., (2021), Cell and Gene Therapy Insights

Haplobanking induced pluripotent stem cells for clinical use.

Sullivan S. et al, (2020), Stem Cell Res, 49

Immunological tolerance: Scanning a barren landscape for signs of sustained growth

FAIRCHILD P. et al, (2020), Cell and Gene Therapy Insights

iPS Cells Reprogrammed from Primary Dendritic Cells Provide an Abundant Source of Immunostimulatory Dendritic Cells for Use in Immunotherapy

Horton C. et al, (2019), STEM CELLS

Boosting Antitumour Immunity through Targeted Delivery of Interferon-α

Fairchild PJ. and Davies TJ., (2019), Trends in Molecular Medicine

Dendritic cells

FAIRCHILD P., (2019)

Immunotherapy with iPSC-derived dendritic cells brings a new perspective to an old debate: Autologous versus allogeneic?

FAIRCHILD PAUL., (2019), Cell and Gene Therapy Insights

Evasion of pre-existing immunity to Cas9: A pre-requisite for successful genome editing in vivo?

FAIRCHILD P. and Wignakumar T., (2019), Current Transplantation Reports

Directed differeintiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset

Fairchild PJ. et al, (2017), Frontiers in Immunology

The adaptive immune response to cardiac injury—the true roadblock to effective regenerative therapies?

Sattler S. et al, (2017), npj Regenerative Medicine, 2

Harnessing the properties of dendritic cells in the pursuit of immunological tolerance.

Horton C. et al, (2017), Biomedical journal, 40, 80 - 93

Beneath the sword of Damocles: regenerative medicine and the shadow of immunogenicity

Fairchild PJ. et al, (2016), Regenerative Medicine, 11, 817 - 829

Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties.

Nordin JZ. et al, (2015), Nanomedicine, 11, 879 - 883

A highly optimized protocol for reprogramming cancer cells to pluripotency using nonviral plasmid vectors.

Zhao H. et al, (2015), Cell Reprogram, 17, 7 - 18

Load More

1
2
3
4
5
6
7